Skip to Main Content

Paper Details

Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancer.
Oral Oncol
0
2023
93VU147T, Cell line, HPV, HPV+ cell lines, HPV-positive head and neck cancer, LRP1B, LRP1B deleted cells, LRP1Bwas, OPSCC, UMSCC47, UWO23, UWO37, cell line panel, cell lines, cisplatin, human papillomavirus, non-targeting control cells, oropharyngeal squamous cell carcinoma, patients, tumour
Carcinoma, Squamous Cell, Cisplatin, Drug Resistance, Neoplasm, Head and Neck Neoplasms, Humans, Neoplasm Recurrence, Local, Oropharyngeal Neoplasms, Papillomavirus Infections, Radiation Tolerance, Receptors, LDL, Squamous Cell Carcinoma of Head and Neck
Author NameAffiliation
Mushfiq H ShaikhUniversity of Western Ontario
Alice DawsonUniversity of Western Ontario
Stephenie D ProkopecOntario Institute for Cancer Research
John W BarrettUniversity of Western Ontario
Peter Y F ZengUniversity of Western Ontario
Mohammed I KhanUniversity of Western Ontario
Sarah E B RyanUniversity of Western Ontario
Matthew CecchiniUniversity of Western Ontario
David A PalmaUniversity of Western Ontario
Joe S MymrykUniversity of Western Ontario
Paul C BoutrosUniversity of California, USA Institute for Precision Health, USA Jonsson Comprehensive Cancer Centre los angeles
Anthony C NicholsUniversity of Western Ontario
  • 1 - 12

Datasets

Release 1.2